罗克韦尔医药 RMTI 深 沪
交易中 05-27 11:02:32 美东时间
0.7635
+0.008
+1.06%
华盛通- 最 高0.7876
- 今 开0.7754
- 成交量 4.66万股
- 最 低 0.75
- 昨 收 0.7555
- 总市值 3013.56万
- 52周最高 2.10
- 市盈率 静 --
- 换手率 0.12%
- 52周最低 0.737
- 委 比 -26.11%
- 总股本 3947.03万
- 历史最高 207.90
- 量 比 0.93
- 振 幅 4.98%
- 历史最低 0.737
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Going On With Rockwell Medical Stock Wednesday?
Rockwell Medical (RMTI) spikes 6.4% premarket. Discover key support and resistance levels as the stock tests its 20-day moving average.
05-20 20:28
Rockwell Medical Signs Three-Year Product Purchase Agreement With Heritage Dialysis
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
05-14 18:07
BRIEF-Rockwell Medical Q1 EPS USD -0.04
BRIEF-Rockwell Medical Q1 EPS USD -0.04 May 07 (Reuters) - Rockwell Medical Q1 sales USD 17.3 million. Q1 operating income USD -1.5 million Q1 net income USD -1.6 million Q1 gross profit USD 2.9 million
05-07 18:00
Rockwell Medical Q1 Earnings Preview
Rockwell Medical (RMTI) is scheduled to announce Q1 earnings results on Thursday, May 7th, before market open. The consensus EPS Estimate is -$0.03 (-200.0% Y/Y) and the consensus Revenue Estimate is ...
05-06 23:22
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Rockwell Medical Q4 sales fall on customer volume reduction
Rockwell Medical Q4 sales fall on customer volume reduction Overview U.S. hemodialysis products maker's Q4 net sales declined yr/yr due to reduced customer volume Company's Q4 gross margin rose to 21%, marking one of its strongest quarters Adjusted EBITDA was positive for Q4 and full-year, achieved
03-26 18:12
Rockwell Medical Sees FY2026 Sales $65.000M-$70.000M vs $75.153M Est
GUIDANCEFor the third year in a row, Rockwell Medical's annual performance was directly in line with its annual guidance. In 2025, Rockwell Medical's achieved net sales, gross margin and Adjusted EBITDA as
03-26 18:08
Rockwell Medical FY2025 net loss widens to $5.3 million; net sales drop 31.72% to $69.3 million
Rockwell Medical FY2025 net loss widens to $5.3 million; net sales drop 31.72% to $69.3 million Rockwell Medical published a press release reporting fourth-quarter and full-year 2025 financial and operational results. Q4 net sales fell 25.9% to USD 18.3 million, driven by reduced purchase volume fro
03-26 18:02
BRIEF-Rockwell Medical Q4 EPS USD -0.01
BRIEF-Rockwell Medical Q4 EPS USD -0.01 Mar 26 (Reuters) - Rockwell Medical Q4 gross profit USD 3.9 million. Q4 net income USD -600 thousand
03-26 18:00
